Should We Keep Meeting This Way?

How will study sections meet in the future? NIH peer review depends on robust meetings where groups of scientists, through vigorous discussion, identify the applications of highest merit. For the last 75 years, until last March, nearly all chartered review committee meetings were held in-person. Today, in response to the pandemic, 90% of all CSR review meetings are run as video (“Zoom”) meetings. CSR is taking steps now so that when all options are back on the table, we can make informed choices about how best to convene review meetings. Continue reading

“All About Grants” Podcast – Alternatives to Animals

Considering alternatives to animals in your application is the topic of our next NIH All About Grants podcast. Drs. Neera Gopee with the NIH Office of Laboratory Animal Welfare and Christine Livingston with the National Center for Advancing Translational Sciences join us for this conversation (MP3 / Transcript). We will go into the 3Rs (replace, refine, and reduce), helpful resources for relevant policies, what’s needed for the vertebrate animal section, role for IACUCs and peer review, as well as organoids, in silico models, and other alternatives…oh my again! Continue reading

NIH Challenges Academia to Share Strategies to Strengthen Gender Diversity

On behalf of the NIH Working Group on Women in Biomedical Careers, the NIH Office of Research on Women’s Health has launched a new challenge competition to promote the advancement of women in leadership roles in academia. It is called the NIH Prize for Enhancing Faculty Gender Diversity in Biomedical and Behavioral Science. Dr. Janine Clayton, Director of the Office of Research on Women’s Health, described the competition as one that will recognize institutions that have successfully and systemically addressed gender diversity and equity issues among faculty members in biomedical and behavioral sciences (see her full post here.) Continue reading

Introducing the Stephen I. Katz Early Stage Investigator Research Grant Program

Stephen I. Katz, M.D., Ph.D., led the National Institute of Arthritis and Musculoskeletal Diseases from 1995 until his passing in 2018. Dr. Katz was a talented physician scientist, NIH leader, and civil servant throughout his career who was profoundly dedicated to mentoring and training the next cadre of scientists. During his memorial service at NIH, you can see this dedication on full display. I, along with countless NIH colleagues, were blessed with Dr. Katz’s mentoring and sage advice. That is why, in his honor, we are pleased to announce the publication of Funding Opportunity Announcements for the Stephen I. Katz Early Stage Investigator Research Project Grant program . Continue reading

Continued Impact of COVID-19 on Biomedical Research

It’s been over eight months since the COVID-19 pandemic crisis struck, changing every facet of life as we knew it. The U.S. biomedical research enterprise was not spared, as lockdowns and severe restrictions on activities took hold across the country. At the time, we offered our perspectives on efforts we could take to cushion the shock. Since that time, much has happened. COVID-19 research has blossomed with impressive results including FDA approval of a therapeutic agent (remdesivir, which was found to have value in a large-scale NIH-funded trial), development of several candidate vaccines that have already made to pivotal Phase 3 trials, and the rapid development of a variety of diagnostic testing platforms. However, research unrelated to COVID has seen a different picture. Continue reading

Did You Miss the 2020 NIH Virtual Seminar on Program Funding and Grants Administration?

Not to worry, the entire conference is still available to you on the event platform until Nov 19! The only thing missing is the immediate access to staff that the “live” event offered. Recordings of the presentations and related materials, as well as a plethora of resources from the Institute and Center Exhibit Hall booths await your exploration. Continue reading

Exceptions to Use of a Single IRB During the COVID-19 Public Health Emergency

Conducting research involving human subjects during COVID? Read here for information on requesting an exception to the use of a single IRB.

NIH released a Guide Notice to inform the extramural research community how NIH is implementing the Office for Human Research Protections (OHRP)’s determination of Exception to the Single IRB Review Requirements for Certain HHS-Conducted or -Supported Cooperative Research Activities Subject to the 2018 Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. Continue reading